This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Crain, B. J. Articles by Sisodia, S. S. Search for Related Content PubMed PubMed Citation Articles by Crain, B. J. Articles by Sisodia, S. S.

American Journal of Pathology, Vol 149, 1087-1095, Copyright © 1996 by American Society for Investigative Pathology

REGULAR ARTICLES

Expression and distribution of amyloid precursor protein-like protein-2 in Alzheimer's disease and in normal brain

BJ Crain, W Hu, CI Sze, HH Slunt, EH Koo, DL Price, G Thinakaran and SS Sisodia
Department of Pathology (Neuropathology Laboratory), Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

Amyloid precursor-like protein-2 (APLP-2) belongs to a family of homologous amyloid precursor-like proteins. In the present study we report on the expression and distribution of APLP-2 in fetal and adult human brain and in brains of patients with Alzheimer's disease. We demonstrate that APLP-2 mRNAs encoding isoforms predicted to undergo post-translational modification by chondroitin sulfate glycosaminoglycans are elevated in fetal and aging brains relative to the brains of young adults. Immunocytochemical labeling with APLP-2- specific antibodies demonstrates APLP-2 immunoreactivity in cytoplasmic compartments in neurons and astrocytes, in large part overlapping the distribution of the amyloid precursor protein. In Alzheimer's disease brain, APLP-2 antibodies also label a subset of neuritic plaques. APLP- 2 immunoreactivity is particularly conspicuous in large dystrophic neurites that also label with antibodies specific for APP and chromogranin A. In view of the age-dependent increase in levels of chondroitin sulfate glycosaminoglycan-modified forms of APLP-2 in aging brain and the accumulation of APLP-2 in dystrophic presynaptic elements, we suggest that APLP-2 may play roles in neuronal sprouting or in the aggregation, deposition, and/or persistence of beta-amyloid deposits.

This article has been cited by other articles:

				H. J. Huttunen, J. Kuja-Panula, and H. Rauvala Receptor for Advanced Glycation End Products (RAGE) Signaling Induces CREB-dependent Chromogranin Expression during Neuronal Differentiation J. Biol. Chem., October 4, 2002; 277(41): 38635 - 38646. [Abstract] [Full Text] [PDF]

				J. Ciesielski-Treska, G. Ulrich, L. Taupenot, S. Chasserot-Golaz, A. Corti, D. Aunis, and M.-F. Bader Chromogranin A Induces a Neurotoxic Phenotype in Brain Microglial Cells J. Biol. Chem., June 5, 1998; 273(23): 14339 - 14346. [Abstract] [Full Text] [PDF]

				J. Ciesielski-Treska, G. Ulrich, S. Chasserot-Golaz, J. Zwiller, M.-O. Revel, D. Aunis, and M.-F. Bader Mechanisms Underlying Neuronal Death Induced by Chromogranin A-activated Microglia J. Biol. Chem., April 13, 2001; 276(16): 13113 - 13120. [Abstract] [Full Text] [PDF]